AMAG Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (22)

Latest Posts

About This Stock More About This Stock
Amag Pharmaceuticals Downgraded To Underweight From Neutral At Piper Jaffray
Article By: The Fly
Wednesday, October 30, 2019 9:30 AM EDT
Piper Jaffray analyst Christoper Raymond downgraded Amag Pharmaceuticals to Underweight from Neutral with a price target of $6, down from $9.
In this article: AMAG
Read
5 Drug/Biotech Stocks Likely To Beat Q3 Earnings Estimates
Article By: Zacks Investment Research
Sunday, October 28, 2018 2:00 PM EDT
There are a number of drug/biotech companies poised to surpass third-quarter estimates. However, given the large number of drug/biotech firms, the task of selecting stocks with possibilities to beat could appear quite daunting.
In this article: REGN, AGN, AMGN, ALNY, AMAG
Read
5 Toxic Stocks To Get Rid Of Or Play Short To Make Gains
Article By: Zacks Investment Research
Thursday, March 30, 2017 2:30 PM EDT
Accurate identification of overpriced stocks and correctly priced stocks is the key to investing success.
In this article: CVA, AMAG, INCY, PTC, ETSY
Read
E Best And Worst Small Cap Stocks - Thursday, March 2
Article By: E.B. Capital Markets
Thursday, March 2, 2017 8:30 AM EDT
The average score in small cap is 56.97. Over the past four weeks, the score's average is 57.85.
In this article: CHE, FVE, HMY, JBT, AMAG
Read
AMAG Pharma Q3 Earnings Up Y/Y, Revenues Beat
Article By: Zacks Investment Research
Monday, November 7, 2016 4:07 PM EDT
AMAG Pharmaceuticals, Inc. reported adjusted earnings of $1.61 per share in the third quarter of 2016, up approximately 77% from the year-ago figure.
In this article: AMAG Also: ANIK, CBM, VNDA
Read

PARTNER HEADLINES

Latest Tweets for $AMAG

No tweets yet!